Mirati Therapeutics (MRTX) Short Interest Ratio & Short Volume → It's time to ween off Chinese lithium! (From Smallcaps Daily) (Ad) Free MRTX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends Mirati Therapeutics Short Interest DataCurrent Short Interest4,390,000 sharesPrevious Short Interest7,400,000 sharesChange Vs. Previous Month-40.68%Dollar Volume Sold Short$257.91 millionShort Interest Ratio2.0 Days to CoverLast Record DateDecember 31, 2023Outstanding Shares70,150,000 sharesPercentage of Shares Shorted6.26%Today's Trading Volume0 sharesAverage Trading Volume2,758,857 sharesToday's Volume Vs. Average0% Short Selling Mirati Therapeutics ? Sign up to receive the latest short interest report for Mirati Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMRTX Short Interest Over TimeMRTX Days to Cover Over TimeMRTX Percentage of Float Shorted Over Time Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution Mirati Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/20234,390,000 shares $257.91 million -40.7%N/A2 $58.75 12/15/20237,400,000 shares $427.65 million +56.1%N/A3.3 $57.79 11/30/20234,740,000 shares $269.00 million -22.2%N/A2.1 $56.75 11/15/20236,090,000 shares $342.32 million +31.8%N/A2.7 $56.21 10/31/20234,620,000 shares $256.55 million -0.9%N/A2 $55.53 10/15/20234,660,000 shares $260.73 million -45.8%N/A2.1 $55.95 Get the Latest News and Ratings for MRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/30/20238,590,000 shares $374.18 million -5.1%N/A4.4 $43.56 9/15/20239,050,000 shares $299.10 million -4.3%N/A7 $33.05 8/31/20239,460,000 shares $351.91 million -1.8%N/A8 $37.20 8/15/20239,630,000 shares $382.60 million +19.6%N/A7.7 $39.73 7/31/20238,050,000 shares $243.67 million -7.9%N/A6.9 $30.27 7/15/20238,740,000 shares $309.66 million +1.6%N/A8.5 $35.43 6/30/20238,600,000 shares $310.72 million +6.6%N/A8.3 $36.13 6/15/20238,070,000 shares $314.49 million +13.5%N/A7.7 $38.97 5/31/20237,110,000 shares $264.21 million +5.2%N/A6.8 $37.16 5/15/20236,760,000 shares $334.21 million -14.8%N/A6.9 $49.44 4/30/20237,930,000 shares $351.38 million -13.6%N/A7.9 $44.31 4/15/20239,180,000 shares $360.32 million -0.9%N/A8.6 $39.25 3/31/20239,260,000 shares $344.29 million +7.7%N/A8.3 $37.18 3/15/20238,600,000 shares $371.26 million -2.4%N/A6.8 $43.17 2/28/20238,810,000 shares $403.85 million -3.9%N/A5 $45.84 2/15/20239,170,000 shares $446.67 million -3.9%N/A4.9 $48.71 1/31/20239,540,000 shares $509.53 million -10.3%N/A4.9 $53.41 1/15/202310,630,000 shares $458.05 million +1.0%N/A5.7 $43.09 12/30/202210,530,000 shares $477.11 million +6.6%N/A5.9 $45.31 12/15/20229,880,000 shares $420.30 million +30.0%N/A5.9 $42.54 11/30/20227,600,000 shares $694.49 million -5.9%N/A5.8 $91.38 11/15/20228,080,000 shares $585.80 million +4.5%N/A8.4 $72.50 10/31/20227,730,000 shares $520.38 million -2.3%N/A10 $67.32 10/15/20227,910,000 shares $528.78 million +2.5%N/A9.4 $66.85 9/30/20227,720,000 shares $539.16 million -3.4%N/A8.4 $69.84 9/15/20227,990,000 shares $659.10 million +7.3%N/A8.1 $82.49 8/31/20227,450,000 shares $603.67 million -1.6%N/A6.7 $81.03 8/15/20227,570,000 shares $653.44 million +8.5%N/A4.8 $86.32 7/31/20226,980,000 shares $449.51 million -13.3%13.7%4.3 $64.40 7/15/20228,050,000 shares $483.16 million -2.2%24.0%5.2 $60.02 6/30/20228,230,000 shares $552.48 million +46.7%24.5%5.6 $67.13 6/15/20225,610,000 shares $302.66 million +19.1%16.7%4 $53.95 5/31/20224,710,000 shares $184.44 million -9.6%9.2%3.9 $39.16 5/15/20225,210,000 shares $296.14 million +24.1%10.2%7.1 $56.84It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 4/30/20224,200,000 shares $259.52 million +14.1%8.2%5.5 $61.79 4/15/20223,680,000 shares $301.54 million +10.8%7.2%5.2 $81.94 3/31/20223,320,000 shares $272.97 million +6.8%6.5%4.7 $82.22 3/15/20223,110,000 shares $240.47 million -7.2%6.1%4.5 $77.32 2/28/20223,350,000 shares $295.77 million +12.8%7.0%5 $88.29 2/15/20222,970,000 shares $318.95 million +2.1%6.2%4.6 $107.39 1/31/20222,910,000 shares $347.16 million +11.1%6.1%5 $119.30 1/15/20222,620,000 shares $325.69 million -4.4%5.5%4.9 $124.31 12/31/20212,740,000 shares $401.93 million -11.0%5.8%5.6 $146.69 12/15/20213,080,000 shares $434.22 million +14.1%6.5%6.1 $140.98 11/30/20212,700,000 shares $369.28 million -16.2%5.7%4.9 $136.77 11/15/20213,220,000 shares $453.34 million -16.6%6.8%5.9 $140.79 10/29/20213,860,000 shares $729.62 million -5.4%8.1%8.3 $189.02 10/15/20214,080,000 shares $727.38 million +1.5%8.6%9.3 $178.28 9/30/20214,020,000 shares $711.18 million +20.4%8.5%9.2 $176.91 9/15/20213,340,000 shares $561.39 million -7.5%7.0%6.6 $168.08 8/31/20213,610,000 shares $612.73 million -0.6%7.6%8.1 $169.73 8/13/20213,630,000 shares $508.82 million No Change7.6%8.2 $140.17 7/30/20213,630,000 shares $581.02 million +0.3%7.6%7.5 $160.06 7/15/20213,620,000 shares $574.46 million +5.2%7.4%6.2 $158.69 6/30/20213,440,000 shares $555.66 million -28.0%7.1%5.7 $161.53 6/15/20214,780,000 shares $796.35 million +4.4%9.8%9.3 $166.60 5/28/20214,580,000 shares $724.33 million +2.2%9.4%9.1 $158.15 5/14/20214,480,000 shares $693.32 million +6.7%N/A8.9 $154.76 4/30/20214,200,000 shares $690.94 million +11.7%N/A8.3 $164.51 4/15/20213,760,000 shares $607.09 million -3.3%N/A8.8 $161.46 3/31/20213,890,000 shares $645.62 million +2.9%N/A9.1 $165.97 3/15/20213,780,000 shares $718.16 million +3.3%N/A8.8 $189.99 2/26/20213,660,000 shares $715.90 million +6.4%N/A8.6 $195.60 2/12/20213,440,000 shares $726.63 million -9.7%N/A8.2 $211.23 1/29/20213,810,000 shares $776.74 million -0.8%N/A8.9 $203.87 1/15/20213,840,000 shares $820.80 million +1.1%N/A7.7 $213.75 12/31/20203,800,000 shares $833.30 million -4.5%N/A7.8 $219.29 12/15/20203,980,000 shares $934.70 million -1.7%N/A8.1 $234.85 11/30/20204,050,000 shares $941.79 million +1.3%N/A7.6 $232.54 11/15/20204,000,000 shares $916 million +7.0%N/A7.5 $229.00 10/30/20203,740,000 shares $822.69 million -13.6%N/A7.2 $219.97 10/15/20204,330,000 shares $829.54 million -3.8%N/A9.8 $191.58 9/30/20204,500,000 shares $747.23 million -5.7%N/A10.9 $166.05 9/15/20204,770,000 shares $751.99 million -0.6%N/A11.3 $157.65 8/31/20204,800,000 shares $716.98 million -1.6%N/A13 $149.37 8/14/20204,880,000 shares $677.10 million -3.4%N/A12.3 $138.75 7/31/20205,050,000 shares $612.62 million +1.8%N/A12 $121.31 7/15/20204,960,000 shares $596.64 million -0.6%N/A10.3 $120.29 6/30/20204,990,000 shares $572.35 million -2.7%N/A9.8 $114.70 6/15/20205,130,000 shares $549.78 million -0.4%N/A9.9 $107.17 5/29/20205,150,000 shares $530.45 million -14.2%N/A9.2 $103.00 5/15/20206,000,000 shares $620.22 million +5.8%N/A10.4 $103.37 4/30/20205,670,000 shares $482.18 million -2.4%N/A10.6 $85.04 4/15/20205,810,000 shares $481.59 million +0.4%N/A11.1 $82.89It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution 3/31/20205,790,000 shares $494.06 million +8.9%N/A9.9 $85.33 3/13/20205,317,200 shares $433.46 million -1.2%N/A9.9 $81.52 2/28/20205,380,000 shares $393.49 million +7.8%N/A9.7 $73.14 2/14/20204,990,000 shares $432.03 million +1.2%N/A8.7 $86.58 1/31/20204,930,000 shares $437.14 million +1.4%N/A8.3 $88.67 1/15/20204,860,000 shares $460.05 million +10.5%N/A6.7 $94.66 12/31/20194,400,000 shares $400.31 million -0.2%N/A6.1 $90.98 MRTX Short Interest - Frequently Asked Questions What is Mirati Therapeutics' current short interest? Short interest is the volume of Mirati Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 4,390,000 shares of MRTX short. Learn More on Mirati Therapeutics' current short interest. What is a good short interest ratio for Mirati Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRTX shares currently have a short interest ratio of 2.0. Learn More on Mirati Therapeutics's short interest ratio. Which institutional investors are shorting Mirati Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirati Therapeutics: Walleye Trading LLC, PEAK6 Investments LLC, and Equitec Proprietary Markets LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mirati Therapeutics' short interest increasing or decreasing? Mirati Therapeutics saw a decrease in short interest in December. As of December 31st, there was short interest totaling 4,390,000 shares, a decrease of 40.7% from the previous total of 7,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mirati Therapeutics' short interest compare to its competitors? Here is how the short interest of companies compare to Mirati Therapeutics: ACADIA Pharmaceuticals Inc. (7.25%), Exelixis, Inc. (3.77%), Syndax Pharmaceuticals, Inc. (11.80%), Royalty Pharma plc (3.47%), BioMarin Pharmaceutical Inc. (1.97%), BeiGene, Ltd. (1.75%), Viatris Inc. (3.61%), Sarepta Therapeutics, Inc. (6.94%), United Therapeutics Co. (9.14%), Dr. Reddy's Laboratories Limited (0.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: General Motors ($4.15 billion), T-Mobile US, Inc. ($3.92 billion), TC Energy Co. ($3.66 billion), Charter Communications, Inc. ($3.35 billion), Coinbase Global, Inc. ($3.32 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.80 billion), Rivian Automotive, Inc. ($2.44 billion), Moderna, Inc. ($2.41 billion), and United Rentals, Inc. ($2.23 billion). View all of the most shorted stocks. What does it mean to sell short Mirati Therapeutics stock? Short selling MRTX is an investing strategy that aims to generate trading profit from Mirati Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mirati Therapeutics? A short squeeze for Mirati Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRTX, which in turn drives the price of the stock up even further. How often is Mirati Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRTX, twice per month. The most recent reporting period available is December, 31 2023. More Short Interest Resources from MarketBeat Related Companies: ACADIA Pharmaceuticals Short Interest Data Exelixis Short Interest Data Syndax Pharmaceuticals Short Interest Data Royalty Pharma Short Interest Data BioMarin Pharmaceutical Short Interest Data BeiGene Short Interest Data Viatris Short Interest Data Sarepta Therapeutics Short Interest Data United Therapeutics Short Interest Data Dr. Reddy's Laboratories Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRTX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTime is Running Out - June 25th Deadline Approaching!Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirati Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mirati Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.